市場調査レポート
商品コード
1402437
肥満手術機器の世界市場の評価:機器タイプ別、手術別、エンドユーザー別、地域別、機会、予測(2017年~2031年)Bariatric Surgery Devices Market Assessment, By Device Type, By Procedure, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
肥満手術機器の世界市場の評価:機器タイプ別、手術別、エンドユーザー別、地域別、機会、予測(2017年~2031年) |
出版日: 2024年01月08日
発行: Market Xcel - Markets and Data
ページ情報: 英文 229 Pages
納期: 3~5営業日
|
世界の肥満手術機器の市場規模は、2023年に22億1,000万米ドル、2031年に33億8,000万米ドルに達し、2024年~2031年の予測期間にCAGRで5.44%の成長が見込まれています。市場は現在変革期にあり、医療の進化を反映したさまざまな要因の複合と、世界中での肥満の流行がそれを促進しています。肥満と、糖尿病や心臓病を含む関連する健康問題の流行により、肥満手術の需要は大幅に伸びています。さらに、技術や手術技術の進歩が進み、肥満手術の効率と安全性を高める革新的な機器が導入されています。世界では、毎年58万人近くが肥満手術を受けています。体重減少のほか、こうした外科手術は2型糖尿病などの肥満に関連する数多くの健康問題の大幅な改善につながります。市場は成長が見込まれる一方、規制当局の承認、手術のコスト、減量薬の発売に関する課題に直面しています。その結果、市場は機会と課題を抱えたダイナミックな様相を呈しており、肥満への対応が急務であることを反映して、依然として力強い成長ペースが予測されます。
市場は、主に肥満とそれに関連する合併症の流行により、大幅な成長を示しています。肥満は死因の第5位を占めています。肥満が世界的に増加し続けていることから、糖尿病、心血管疾患、代謝障害などの疾患の発生率が増加する見込みです。肥満手術は肥満患者にとって重要な治療オプションとなっています。医療提供者が患者の転帰と安全性の向上に努める中、肥満手術に対する需要の急増が、先進技術を利用した革新的な肥満手術機器の市場を牽引しています。
世界保健機関(WHO)によると、世界には肥満と分類される人が10億人以上おり、その内訳は成人6億5,000万人、若者3億4,000万人、小児3,900万人です。その数は増加の一途をたどっています。WHOは、2025年までに成人から小児までの約1億6,700万人が過体重や肥満によって健康状態が悪化すると予測しています。
肥満手術機器の技術の進歩は、精度と患者の転帰を高めることで市場に革命をもたらしました。ロボット支援手術システムの利用は、外科医が手術中に精度と制御を得ることを可能にしました。これらのロボットシステムは、手術部位の視覚化、器用さの向上、従来の腹腔鏡ツールでは困難または不可能と考えられていた複雑な手術に取り組む能力を提供します。さらに、新しいObalon Balloonや腹腔鏡下調節胃バンディング術などの低侵襲治療が受け入れられつつあり、肥満手術に革命をもたらしています。小さな切開創と特殊な器具を伴うこれらの手術は、周辺組織の損傷を大幅に軽減し、開腹手術に比べて痛みの軽減、速い回復、合併症の減少につながります。さらに、術後回復強化(ERAS)プロトコルの採用は、手術の全行程を通じてエビデンスに基づく戦略で構成し、合併症を最小限に抑え、回復を促進する上で極めて重要であり、この分野の絶え間ない進化をさらに強調しています。
機器タイプ別に見ると、低侵襲手術と非侵襲手術の中で、低侵襲手術機器が支配的なセグメントとして浮上しています。これらの機器は、従来の開腹手術に代わるより低侵襲な選択肢を提供し、患者の外傷の軽減、回復時間の短縮、合併症の減少をもたらすため、手術の分野に革命をもたらしています。低侵襲手術機器には、腹腔鏡、トロッカー、ロボット支援システムなどのさまざまなツールや機器が含まれ、外科手術の精度、可視化、効率が大幅に向上しています。その多用途性と実証された利点により、多くの外科医に好まれ、低侵襲手術と非侵襲手術の両方で大きな市場シェアを占めています。
北米が世界市場で突出した地位を有しており、一貫して最高のシェアを占めています。これは、この地域の業界における優位性を強調する複数の要因によるものです。北米は肥満と関連する疾患の有病率が高く、これが肥満手術、ひいては肥満手術機器の需要を促進しています。同地域の強固な医療インフラ、革新的な技術、熟練した医療従事者は、肥満手術の分野における同地域のリーダーシップにさらに寄与しています。
さらに、医療の革新への重視とともに、広範な研究開発活動により、先進の肥満手術機器の継続的な進化と採用がなされています。米国のFDAのような規制機関は、承認を迅速化し、安全基準を確保する上で極めて重要な役割を果たしており、市場成長を促す環境を育んでいます。肥満に伴う健康リスクに対する認識が高まり続け、肥満手術の利点がより明白になることから、北米市場は世界情勢において突出した地位を維持すると予測されます。
当レポートでは、世界の肥満手術機器市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢と見通しなどを提供しています。
With a CAGR of 5.44% for the forecast period between 2024 and 2031F, the size of the global market for bariatric surgical equipment was estimated at USD 2.21 billion in 2023 and is projected to reach USD 3.38 billion in 2031. The global market for bariatric surgery devices is currently undergoing a transformative phase, driven by a combination of factors that reflect the evolving landscape of healthcare and the growing prevalence of obesity around the globe. The demand for bariatric procedures is growing significantly due to the increasing prevalence of obesity and associated health problems including diabetes and heart disease. Additionally, ongoing advancements in technology and surgical techniques have introduced innovative devices that enhance the efficiency and safety of bariatric procedures. Globally, close to 580,000 individuals undergo bariatric surgery every year. Besides weight loss, these surgical procedures lead to substantial improvements of numerous health issues associated with obesity such as type 2 diabetes. Despite the promise of growth, the market faces challenges related to regulatory approvals, cost of procedure, and the launch of weight loss drugs. As a result, the market exhibits a dynamic landscape with opportunities and challenges, and the pace of growth is expected to remain strong, reflecting the urgency of addressing obesity.
The global bariatric surgery devices market is experiencing substantial growth, primarily due to the increasing prevalence of obesity and associated health complications. Obesity is the fifth leading cause of death. As obesity continues to rise worldwide, the incidence of conditions like diabetes, cardiovascular diseases, and metabolic disorders will increase. Bariatric surgery has become an important treatment option for obese patients. The surge in demand for bariatric procedures has driven the market for innovative and technologically advanced bariatric surgery devices, as healthcare providers strive to enhance patient outcomes and safety.
According to the World Health Organization (WHO), there are over 1 billion individuals globally who are classified as obese, comprising 650 million adults, 340 million adolescents, and 39 million children. The number is on a continual rise. WHO projects by 2025, around 167 million people, spanning both adults and children, will experience deteriorating health due to excess weight or obesity.
Technological advancements in bariatric surgery devices have revolutionized the market by enhancing precision and patient outcomes. The utilization of robotic-assisted surgery systems has allowed surgeons to achieve precision and control during procedures. These robotic systems offer improved visualization of surgical area, enhanced dexterity, and the ability to tackle complex surgeries that were once considered challenging or impossible with traditional laparoscopic tools. Moreover, the growing acceptance of minimally invasive treatments, such the novel obalon balloon and laparoscopic adjustable gastric banding, has revolutionized bariatric surgery. These techniques, involving small incisions and specialized instruments, significantly reduce trauma to surrounding tissues, leading to reduced pain, faster recovery, and fewer complications compared to open surgery. Additionally, the adoption of Enhanced Recovery After Surgery (ERAS) protocols, which consists of evidence-based strategies throughout the surgical journey, has been pivotal in minimizing complications and expediting recovery, further emphasizing the continual evolution of the field.
In July 2023, leading medical device manufacturer Genesis MedTech announced that the National Medical Products Administration (NMPA) of China approved the market release of its groundbreaking ArtiSential line of articulating laparoscopic instruments. With its ability to replicate a surgeon's wrist and finger movements, ArtiSential is a laparoscopic surgical instrument that offers several clinical benefits that improve surgical accuracy and results. The double-joint end-effector offers complete access to slender surgical sites with 360 degrees of rotation. The surgeon can experience an authentic endoscopic procedure due to its fully mechanical operation and tactile feedback conduction.
Based on device type, minimally invasive surgical devices have emerged as the dominant segment, amongst minimally invasive and non-invasive surgical procedures. These devices have revolutionized the field of surgery, as they offer less invasive alternatives to traditional open surgeries, resulting in reduced trauma to patients, shorter recovery times, and fewer complications. Minimally invasive surgical devices encompass a wide array of tools and equipment, including laparoscopes, trocars, and robotic-assisted systems, which have significantly enhanced the precision, visualization, and efficiency of surgical procedures. Their versatility and proven benefits have made them preferred choice for many surgeons, contributing to their substantial market share in both minimally invasive and non-invasive surgical settings.
North America holds a prominent position in the global bariatric surgery device market, consistently accounting for the highest share. It is attributed to several key factors that underscore the region's dominance in the industry. North America has high prevalence of obesity and related health conditions, which drives the demand for bariatric surgeries and, consequently, bariatric surgery devices. The region's robust healthcare infrastructure, innovative technology, and skilled medical professionals further contribute to its leadership in the field of bariatric surgery.
Moreover, extensive research and development activities, alongside a strong emphasis on healthcare innovation, have resulted in continuous evolution and adoption of advanced bariatric surgery devices. Regulatory bodies, such as FDA in the United States, play a pivotal role in expediting approvals and ensuring safety standards, fostering an environment conducive to market growth. As awareness about the health risks associated with obesity continue to grow and the benefits of bariatric surgery become more apparent, North American market for bariatric surgery devices is expected to maintain its prominent position in the global landscape.
Like many sectors of the healthcare industry, the global bariatric surgery devices market experienced a significant impact due to the COVID-19 pandemic. At the beginning of the pandemic, there was a sharp decrease in bariatric surgical procedures conducted globally. As hospitals and healthcare facilities worldwide redirected their resources and focused on the urgent needs of COVID-19 patients, the volume of elective and non-urgent surgeries, including bariatric procedures, declined. Restrictions on non-essential medical procedures, coupled with concerns over virus transmission, led to the postponement or cancellation of many bariatric surgeries. It resulted in a temporary reduction in demand for bariatric surgery devices and associated equipment. One-fifth of surgeons expressed hesitation to resume bariatric surgeries until the COVID-19 pandemic had ended completely.
The global bariatric surgery devices market is a fast-growing competitive market, with major players like Intuitive Surgical Inc., Johnson & Johnson, SPATZ FIGA, Inc., etc. These companies have innovative and technologically advanced solutions, robust research and development, and significant market shares. With the rising demand for minimally invasive surgeries, the market players are producing better solutions. The global bariatric surgery devices market is expected to grow, driven by the growing prevalence of obesity and related disorders, increasing preference for minimally invasive surgery and technological advancement.
In May 2023, Olympus announced the market release of POWERSEALTM Sealer/Divider for Europe, Middle East, and Africa (EMEA). This versatile and advanced bipolar device provides state-of-the-art sealing, dissection, and grasping capabilities for surgeons specializing in various medical fields, catering to both laparoscopic and open surgical procedures. It enhances Olympus' advanced energy portfolio, complementing the unique hybrid technology of THUNDERBEAT, further strengthening their offerings.
In May 2021, Standard Bariatrics announced the US Food and Drug Administration granting clearance for its innovative Titan SGS stapling technology, which is uniquely tailored for bariatric sleeve surgery. The groundbreaking design of the Titan SGS provides surgeons conducting sleeve gastrectomy procedures with the longest continuous staple cutline in the industry, with a length of 23 centimeters.
All segments will be provided for all regions and countries covered:
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.